Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Retinal Nerve Fiber Layer Thickness, Brain Atrophy, and Disability in Multiple Sclerosis Patients.
Neuroinflammation and demyelination from the point of nitrosative stress as a new target for neuroprotection.
The BDNF val(66)met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls.
Sex drive and sexual desire.
Role of Hemichannels in CNS Inflammation and the Inflammasome Pathway.
Helminth Products Protect against Autoimmunity via Innate Type 2 Cytokines IL-5 and IL-33, Which Promote Eosinophilia.
Bridging network divides: Building capacity to support aging with disability populations through research.
Mind the gap! Lay and medical perceptions of risks associated with the use of alternative treatment and conventional medicine.
Deep grey matter involvement in multiple sclerosis: key player or bystander?
Multiple sclerosis.
The physical anthropometry, lifestyle habits and blood pressure of people presenting with a first clinical demyelinating event compared to controls: The Ausimmune study.
POEMS Syndrome in a Juvenile Initially Diagnosed as Treatment Resistant Chronic Inflammatory Demyelinating Polyneuropathy.
Association between chronic stress-induced structural abnormalities in Ranvier nodes and reduced oligodendrocyte activity in major depression.
Neurological disorders and celiac disease.
Pupillary response to sparse multifocal stimuli in multiple sclerosis patients.
Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis.
Neuroinflammation: no rose by any other name.
Signaling through three chemokine receptors triggers the migration of transplanted neural precursor cells in a model of multiple sclerosis.
Age-dependent differences in microglial responses to systemic inflammation are evident as early as middle age.
Intrathecal Baclofen in Spinal Spasticity: Frequency and Severity of Withdrawal Syndrome.
Utilized Resources of Hope, Orientation, and Inspiration in Life of Persons with Multiple Sclerosis and Their Association with Life Satisfaction, Adaptive Coping Strategies, and Spirituality.
Generation and preclinical characterization of an antibody specific for SEMA4D.
Anesthetic technique in a patient with multiple sclerosis scheduled for laparoscopic nephrectomy for a renal tumor: a case report.
Comparison of diabetes patients with "demyelinating" diabetic sensorimotor polyneuropathy to those diagnosed with CIDP.
Pages
« first
‹ previous
…
545
546
547
548
549
550
551
552
553
…
next ›
last »